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What is new: 
• Methodological differences among QEs must be carefully coded to capture possible 
sources of variation. 
• Information on the statistical and design controls used in QE studies is of critical 
importance in reviews of QEs. 
• If effects do not all estimate the same quantity the meta-analyst should code and examine 
differences due to effect-size metric. 
• When extracting partial (adjusted) effect sizes meta-analysts should document model 
complexity, and examine its role in between-studies differences. 
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ABSTRACT 
Objective: To identify variables that must be coded when synthesizing primary studies that use 
quasi-experimental designs.       
Study Design and Setting: All quasi-experimental (QE) designs.  
Results: When designing a systematic review of QE studies potential sources of heterogeneity – 
both theory-based and methodological – must be identified.  We outline key components of 
inclusion criteria for syntheses of quasi-experimental studies. We provide recommendations for 
coding content-relevant and methodological variables, and outlined the distinction between 
bivariate effect sizes and partial (i.e., adjusted) effect sizes. Designs used and controls employed 
are viewed as of greatest importance. Potential sources of bias and confounding are also 
addressed.   
Conclusion: Careful consideration must be given to inclusion criteria and the coding of 
theoretical and methodological variables during the design phase of a synthesis of quasi-
experimental studies. The success of the meta-regression analysis relies on the data available to 
the meta-analyst. Omission of critical moderator variables (i.e., effect modifiers) will undermine 
the conclusions of a meta-analysis.  
KEYWORDS 
Meta-analysis, quasi-experiment, bivariate effect size, partial effect size, moderator variables, 
effect modifiers 
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In this article we describe the data that should be collected by authors of systematic 
reviews of quasi-experiments (QEs). Broadly, the categories of data that need to be collected 
from QE studies are the same as those needed for systematic reviews of experimental studies 
(i.e., randomized controlled trials), namely information needed to: (a) describe the included 
studies in terms of their key characteristics, (b) assess the risk of bias in included studies, and (c) 
compute study-level effect sizes for use in meta-analysis and code predictors for use in 
moderator analysis. These three categories are not mutually exclusive. Because guidelines for 
authors on collecting data from experimental studies are well established, we focus here on 
issues that require particular attention when collecting data from QE studies, referring readers to 
already published sources of guidance where available (e.g., Higgins et al., 2013; Valentine & 
Thompson, 2013). 
We first consider some general issues in data collection from QEs, then discuss inclusion 
criteria for systematic reviews of QEs. We discuss recommendations for the coding of content-
relevant and methodological variables. After that we describe information needed to compute 
effect sizes from QE designs.  Finally, we provide recommendations for the systematic review of 
QE studies and highlight areas of future study. 
General Issues 
When a randomized control trial (RCT) cannot be performed the next best source of 
evidence is often a well-designed QE (Bärnighausen et al. 2017).  Thus, when reviewers want to 
explore the effects of interventions that have not been studied using RCTs, they may rely on 
syntheses of QEs (Lavis et al. 2017, Rockers et al. 2017a, Rockers et al. 2017b).  The first issue 
that reviewers will face is what is meant by “QE”.  Many different frameworks have been 
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proposed to define and organize QE designs (Campbell & Stanley, 1966; Rockers et al., 2015).  
For instance, the original work of Campbell and Stanley (1966) labels different designs (e.g., 
time-series, regression discontinuity) simply as quasi-experimental designs. On the other hand, 
Rockers et al. (2015) distinguish between different categories of quasi-experiments, based on 
whether the designs can control for all or only some unobserved confounding. Regardless of the 
definition of QEs used for a particular systematic review, quasi-experiments are observational 
studies that attempt to establish causation. Thus, QEs and experiments share the presence of 
interventions that precede the measurement of the outcome(s).  Here we focus on QE designs 
that include control groups, thus some matters particular to designs such as regression 
discontinuity and time series (e.g., bandwidth, numbers of observations) are not treated here.   
In randomized control experiments, investigators randomly allocated units to intervention 
and control arms. By definition, QEs lack random assignment of units by investigators.  Random 
assignment creates the expectation of group equivalence on all observed and unobserved 
variables at baseline. Confounding occurs when individual participant characteristics (e.g., 
prognostic factors) that are associated with the outcome differ at baseline between participants in 
treatment and control groups. Researchers can attempt to create a reasonable counterfactual by 
accounting for confounders using statistical controls or design features such as matching. 
Sometimes critical covariates can be identified a priori (and thus their presence could be coded), 
but in the primary studies statistical control variables will be limited to the observed covariates 
available to the researcher.  
Clearly then, information on the statistical controls used in studies will be central in 
reviews of QEs.  These may or may not adequately model the selection process, and therefore 
may or may not account for a reasonable degree of bias, and the degree to which bias reduction 
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occurs is the key issue for the quality of inference from a QE. Consequently covariates must be 
examined with care, and one approach to handling the use of covariates is to code those that are 
significant and function to reduce bias in each primary study. Alternately one could make an 
overall assessment about whether the collection of controls (statistical or otherwise) appeared to 
function well for the particular study at hand and reduce bias to some reasonable degree. This 
more-global kind of judgment is more subjective, and potentially harder to make, but allows for 
the fact that different covariates may be appropriate for different study configurations. 
The potential for heterogeneity in collections of QE studies is greater than in sets of 
experiments (Deeks et al., 2003).  Thus, in the design phase of a systematic review of QE studies 
potential sources of heterogeneity – both content-relevant (e.g., relating to the content and/or 
process of the intervention) and methodological – must be identified.  Coding these potential 
sources of heterogeneity allows for empirical assessment of their predictive power.  Each 
systematic review of QE studies will differ in the content-relevant variables (e.g., intervention or 
population features, etc.) that need to be coded. However, all systematic reviews of QE studies 
should extract information regarding a core set of methodological variables – and of course the 
exact methodological issues pertinent to inferences may differ across systematic reviews. 
Therefore the discussion below should be seen as a starting place for identifying sources of 
heterogeneity, not as a single set of recommendations for all reviews.      
Inclusion Criteria 
Inclusion criteria are a central element in any systematic review (Cooper, 2010).  Both 
the Campbell and Cochrane Collaborations ask for clear inclusion criteria in their protocols.  The 
inclusion criteria must be directly connected to the research question(s) and should clearly 
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discriminate between what studies are kept for analysis and what studies are not.  For instance, if 
a systematic review of QE studies is intended to include only QEs which used a regression 
discontinuity approach, the inclusion criteria should clearly state this.   
A key element of the inclusion criteria for a review of QEs is information about how 
control variables will be treated. Because selection bias is a major concern, the reviewer must 
have a deep understanding of how selection effects operate in the studies in the review, then use 
this knowledge to outline potential important control variables (e.g., age, gender, etc.). The 
reviewer also must decide how the included studies should have handled those variables. For 
example, inclusion criteria may allow studies to report on participants of any age. For age to be 
investigated as a possible source of heterogeneity across studies (i.e., to be able to use age as a 
moderator), it must be coded at the study level, and it must vary across studies. However, just 
coding the average age of participants does not achieve control of age-related selection bias 
within each study. Thus the inclusion criteria might also specify that age should be controlled 
within each study, for example, by using age as a covariate or a blocking variable. In such a case 
the reviewer would not select a study with a broad age range unless age was used as a covariate. 
On the other hand, a study with a sample of only elderly participants in a narrow age range may 
be eligible even if it does not covary or match on age, simple because participant ages do not 
vary greatly, thus care controlled by design (i.e., by restricting the sample).  
Coding Content-relevant and Methodological Variables 
The particular variables that are theoretically relevant for any given review will depend 
on the topic of interest.  Thus, choosing specific content-relevant variables to extract must be 
done in the context of the particular topic under consideration in the systematic review. This is 
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true for all research syntheses, not just those that include QE studies. Nevertheless, some key 
variables can be identified. Because QEs typically evaluate interventions, aspects of the 
treatment are critical. Duration, intensity, and information about implementation are needed. If a 
variety of individuals implement the treatment, their characteristics should be tracked. Variables 
such as amount of training received or experience of the implementers may affect strength of the 
treatment effect. Information on fidelity of intervention will enable to reviewers to examine 
whether the strength of an intervention varies according to how well it is put in place. Likewise, 
whether a treatment has a manual, and whether the manuals are used in practice, may relate to 
program efficacy.  Population target, types of outcomes and how they were measured, and other 
contextual factors relevant for the intervention should be extracted as well.  Perhaps obviously, 
the meta-analyst should extract setting characteristics as well.  Frameworks such as PICOS 
(Patients, Intervention, Comparisons, Outcomes, Study Design; Richardson et al., 1995) or 
MUTOS (Methods, Units, Treatments, Observations, Settings; Cronbach, 1982; Becker, 1996; 
Becker & Aloe, 2008) can guide selection of relevant features. 
Careful attention also needs to be paid to the designs and analyses used in the primary 
studies.  If these are dissimilar, inclusion of a meta-analysis (i.e., quantitative summary) in the 
systematic review must be justified. Thus, reviewers should not only code how the primary study 
analyzed the data, they should also code the specific predictors used, and details of how the 
outcome(s) were measured. As mentioned above, information should be coded on whether the 
important statistical assumptions of the QE analysis were met.  The success of adjustments for 
confounders and selection bias in a QE relies on meeting the assumptions of the analyses 
performed.   
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In the same manner, when the QE design includes a control group the presence (or lack) 
of evidence of the comparability of groups on key variables should be coded. At minimum, the 
presence or absence of information on assumptions (e.g., in the form of dummy variables) and 
baseline group comparisons should be coded. Then methods such as meta-regression can be used 
to explore systematic differences between primary studies that do or do not provide this 
information.   
For a QE study using a regression discontinuity design (Thistlewaite & Campbell, 1960) 
the reviewer should code information about the assumption that the treatment effect is 
discontinuous at the cutoff. When specific information about assumptions is not given, reviewers 
should request such information from the primary study authors.  We see this as being analogous 
to the queries meta-analysts make of RCT designs to verify that randomization was successfully 
implemented, that attrition was low, and so forth. 
Coding Information on Effect Sizes  
The term effect size is commonly used in meta-analysis to refer to the study outcome.    
In the social sciences, some meta-analysts refer to three families of effect sizes, namely the d 
family, r family, and p family (Lipsey & Wilson, 2001). The d family includes standardized 
mean differences (for a continuous outcome and a grouping variable).  The r family includes 
correlation coefficients (usually between two continuous variables).  The p family includes 
proportions or quantities related to proportions such as odds ratios (reflecting relations between 
dichotomous variables). Effect sizes can often be transformed from one metric to another (see 
Lipsey & Wilson, 2001).  The choice of what quantity best represents study outcomes will 
depend on the design and analysis in the primary study, and the desired inferences for the 
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systematic review.  All three families may be appropriate as effects, depending on the QR 
design. 
Bivariate and Partial Effects 
The distinction between bivariate effect sizes and partial (i.e., adjusted) effect sizes has 
until recently been largely ignored (some notable exceptions are Aloe, 2014; Aloe & Becker, 
2012; Aloe & Thompson, 2013; Keef & Roberts, 2004).  However, given the importance of 
control variables in QEs, this distinction is highly relevant for effect-size computation for QEs. 
Bivariate effect sizes in all effect-size families portray relationships between two variables.  In 
contrast, partial effect sizes gauge the strength of relationships between two variables adjusting 
for the effects of other variables in the model.  For instance, one primary study may report the 
relationship between breastfeeding and the risk of infant overweight as an odds ratio – a bivariate 
effect. Another study may report the relationship between breastfeeding and the risk of infant 
overweight as an odds ratio adjusted by (or conditional on) gender, birth weight, and 
socioeconomic status, which would be a partial effect.  This distinction between bivariate and 
adjusted effects is important because the magnitudes and even the directions of adjusted effects 
can differ greatly from those of unadjusted effects. Also certain control factors may lead to large 
adjustments whereas others have no impact. Thus coding the presence of key control variables 
allows the reviewer to analyze variation among partial effects if a meta-analysis is conducted. 
Because QE designs aim to assess the effectiveness of treatments, the fundamental effect 
of interest is likely to be based on mean differences or comparisons of counts or odds. Because 
of the complexities of QEs, the effect size will nearly always be something other than the simple 
standardized mean difference (d, as in Hedges & Olkin, 1985), or the simple odds ratio. Most 
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effect sizes will likely be partial effects and their magnitudes will depend on what is adjusted for 
in each study. Therefore meta-analysts must code detailed information about the specific controls 
used – either design controls, statistical control variables, or both – during data extraction. 
For each study (or sample, for studies with multiple samples), the meta-analyst should 
extract both an estimate of effect size and its standard error (SE). If a study does not report 
standard errors or the information needed to derive them – for example, if a study reports an odds 
ratio but does not provide the underlying success rates – the meta-analyst may be able to 
compute them from related test statistics (e.g., t tests of slopes). Effect estimates can also be 
obtained from observed significance levels, but if the SE cannot be obtained it may have to be 
imputed, or the study may need to be dealt with in a narrative fashion.  
Example. In this section we illustrate the differences between bivariate and partial effect 
sizes, for the case of standardized mean differences.  When a randomized control trial is 
conducted and sufficient statistics reported, it is straightforward to compute the standardized 
mean difference.  Assume that the study compares a treatment group with a control group.  The 
standardized mean difference is defined (Hedges & Olkin, 1985) as   
                =  ,                                                    (1) 
where 
and 
are the sample means of the treatment and control groups, respectively, and s is 
the pooled sample standard deviation. When means or standard deviations are not provided, 
meta-analysts typically obtain g by transforming other reported statistics (see Lipsey & Wilson, 
2001, for specific formulas). For instance, if a t test between independent means is conducted 
and the t statistic (t) is reported, then a little algebra yields 
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     =  ,                            (2) 
where  and  are the sample means of the treatment and control group. Equations 1 and 2 are 
algebraically equivalent. 
Because QEs tend to rely on regression analysis, the outcome of interest is predicted by 
the focal predictor (i.e., the variable representing group membership) and other observed 
covariates (i.e., the analysis of covariance or ANCOVA model).  Keef and Roberts (2004) 
proposed a partial effect size for group differences based on ANCOVA. Specifically, their model 
was 
Yj = α + γ Dj + β2 X2j + ... βp Xpj + ej, 
where Y is an outcome score for person j, D is a dummy variable representing a treatment or 
group effect, and X2 through Xp are covariates. The errors ej are assumed to have common 
variance  estimated as . Keef and Roberts proposed using gp = as a partial index of 
treatment effects, since  represents an adjusted mean difference (accounting for all covariates 
in the model) and is the residual variance – essentially the variance of the Y scores, adjusting 
for the effects of all predictors. If the meta-analyst does not have access to  the standard 
deviation (sY) of the outcome can be used. Moreover, for some studies meta-analysts may prefer 
to standardize the partial effect size by the within groups pooled standard deviation to avoid 
extra artificial variability in (Johnson & Eagly, 2000).  Other partial effect sizes estimated as a 
function of t-test statistics, such as partial correlations, can overestimate the magnitude of partial 
effects. This occurs because typically covariates reduce the size of the standard error of the slope 
of interest (i.e., the denominator of the test) relative to those in other studies.      
2
eσ
2
es es/γˆ
γˆ
2
es
es
2
es
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In ANCOVA scenarios with significant covariates, the bivariate and partial effects will 
typically disagree; thus,  ≠ .   If the primary study achieves the goal of adjusting for all of 
the ‘right’ variables, this partial effect will approximate the bivariate effect obtained from a 
randomized control trial (i.e.,  ≅ ).  However, adjusting statistically many not be the same as 
controlling by design. Evidence on when such effects may be comparable comes from a study 
conducted by Shadish and colleagues (2004).  Students were randomly assigned to two 
assignment mechanisms (i.e., random assignment and nonrandom assignment) (Shadish, Clark, 
& Steiner, 2004) then were assigned to treatment and control conditions using that mechanism.  
Data from the randomized and nonrandomized groups were analyzed and the extent to which the 
nonrandomized groups results deviated from the experimental results was conceived of as bias. 
The authors reported that both linear-regression and propensity-score adjustments reduced 95% 
and 96% of this observed bias, respectively. However, typically, a great deal must be known 
about the topic of interest and the mechanisms behind how the treatment works for adjustments 
to be this effective.  For example, Shadish et al. first explored theoretical considerations related 
to why participants might choose a particular intervention condition, and then measured several 
indicators of ability and other individual differences, demographics, and attitudes toward the 
intervention; these were used as control variables.  
Primary Studies Reporting Multilevel Models  
Clusters of individuals in neighborhoods, villages, or other units such as medical 
practices may be recipients of treatments studied in QEs. The nesting involved in clustered study 
designs needs to be considered in the computation and analysis of effect sizes (e.g., Hedges, 
2007; 2011). Reviewers should extract the intraclass correlation (or information needed to 
compute it), and the number of units that are represented at different levels (e.g., patient at level 
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1, clinic at level 2), from each multilevel model.  This information can then be used to correct the 
effect size and its variance (see Hedges, 2007).  
Dependence 
 One important assumption of typical meta-analytical techniques is independence of the 
effect sizes.  When a study reports results for multiple outcomes, or if the same outcome is 
reported at multiple time points, the several effects will be interdependent. Or, sometimes 
primary studies will report several models, often to show the contributions of different sets of 
predictors. Some meta-analysts extract and analyze effects from every model in each primary 
study.  However if all such effects are included in one meta-analysis, the independence 
assumption fundamental to univariate meta-analytic statistics is violated. In addition studies 
reporting many models will have undue influence if the effects from them are treated as 
independent. To account for such dependence requires knowing or imputing information on 
correlations among variables (which should be recorded if they are reported).  A range of 
approaches exist to modeling dependence (see Becker et al., this issue; Gleser & Olkin, 2009) 
but these can be very hard to implement  because data on the degree of dependence is often 
unavailable. A simple approach when several competing models are reported in a primary study 
would be to select the one that best controlled for potential biases, and to extract the effect-size 
index from that analysis.  
Effect-Size Metric 
Given the different designs and analyses used and reported in primary studies, the metrics 
of the available estimated effect sizes may not always be immediately comparable. A systematic 
review of QEs must be particularly careful about this, because of the myriad of different designs 
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and analyses used within QEs.  For instance, assume that a reviewer is interested in the effect of 
maternal alcohol consumption on birth weight.  It is conceivable that one QE might use an 
instrumental-variables approach (e.g., state alcohol sales tax as an instrumental variable) while 
another QE uses propensity score matching (e.g., participants matched on their state’s alcohol 
sales tax and ten other variables).  Several questions need consideration: Are effect sizes from 
these different QE designs comparable? Should effect sizes from these two studies be combined 
into the same aggregate? If they are estimating clearly different quantities, the answer is no. 
Studies with different designs may need to be analyzed separately, especially when design type 
is confounded with things such as the population type or the type of effect size that is reported 
(as in Kownacki & Shadish, 1999).  Moreover, some QE studies may report the average 
treatment effect on the treated (ATT), whereas other QE studies investigating the same matter 
may report the average treatment effect (ATE), which involves both treatment and control groups 
(Holland, 1986; Imai et al., 2008). Yet another QE may report the local average treatment effect 
(LATE).  Are these three quantities comparable? Should these three quantities be combined into 
the same aggregate? The answers to these questions will depend on the particularities of the 
primary studies, though users should be prepared for the answer to be “No”. That said, the 
impact of combining these three quantities in meta-analysis is an area that deserves further 
investigation.  Regardless of whether different estimators are thought to be roughly comparable, 
data on the nature of the specific QE designs and analyses must be extracted from studies.  That 
information can be used to empirically investigate differences in estimated effects and variability 
within and between specific designs (see Becker et al., same issue). Arguably what should be 
combined in a meta-analysis depends on the specific research question. In some cases differences 
in type of effect size can be seen as potential sources of variability.  However, in other situations 
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where quite disparate quantities are being estimated, having such differences would be 
problematic for the quantitative synthesis.  
General Practical Recommendations 
As is true for primary studies, decisions made during each step of a systematic review 
have consequences for the next steps of the review.  Thus, careful planning and consideration of 
a protocol is a vital component of any systematic review.  For instance, if an important rule is 
omitted from the inclusion criteria, the collection of studies may not accurately represent the 
desired population (e.g., if a systematic review was not specific about the operational definition 
of QE, relevant studies may be omitted and/or irrelevant studies may be included).  If a particular 
factor is ignored at the coding stage, information will not be available for the reviewer in the 
data-analysis stage (e.g., if a systematic review did not code which covariates were used in the 
QEs, this information will not be available for use as potential moderator variables).  Thus, the 
design phase (i.e., protocol development) of any systematic review of QEs is critical. Reviewers 
should anticipate, then code, all possible factors (substantive/theoretical, design, analysis, and so 
on) that may lead to differences in QE outcomes.   
Many claims about similarities and differences among diverse QE designs and analyses 
can be empirically explored when covariates are coded.  When the coded covariates are too 
numerous to be included individually in a single analysis the meta-analyst may be able to create 
higher level constructs that represent several related covariates. Similarly, different QE designs 
adjust for confounders and selection bias through different mechanisms (see for example Hernan, 
Hernandez-Diaz, & Robins, 2004). By coding the specifics regarding designs and analyses of 
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each included primary study the relationships of these features to the treatment effects can be 
explored as well. 
Conclusions 
The data-collection stage of any meta-analysis is crucial because other stages such as data 
analysis will depend on what has been coded.  In addition to effect-size information, study 
characteristics that could potentially modify the magnitude of effects across studies should be 
systematically coded.   
Although many alternative QE designs exist, the overall goal of all of the designs is to 
control for endogenous selection in the assignment of people to intervention and control groups, 
similar to trials.  When primary studies report on QEs, they commonly use analyses based on 
regression models; the predictors included in these models are key to ensuring that the studies 
provide credible evidence about treatment effectiveness.  However, no statistical technique can 
correct for poor design and/or poor data in a primary study or a meta-analysis.  Thus, careful 
attention must be given to the collection of data from QE studies included in a systematic review.   
We have provided suggestions about what variables should be coded when synthesizing 
QEs, and outlined some considerations regarding effect sizes.  As is true for any meta-analysis of 
aggregate data, the goal in the data-extraction phase in a synthesis of QEs is to extract from each 
primary study the best evidence on the effects of the intervention.   Attending to those features 
that ensure group comparability in comparative QE designs should support credible analyses and 
synthesis conclusions. 
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